Immunotech S.A.S.

What Immunotech S.A.S. does

Immunotech S.A.S. is a French private company operating under the Société par Actions Simplifiée (S.A.S.) legal form, with a name indicating a focus on immunology-related technology or research. No further substantive information is available in the aggregated source data: the input contains no description of products, services, technology stack, business model, target customers, pricing, go-to-market motion, geographic footprint, leadership, funding history, headcount, or operational status. The only raw source artifact is a tracking pixel hosted on beckmancoulter-amh.com (a Beckman Coulter affiliate domain associated with biomedical and life-sciences instrumentation), which yields no verifiable company-level content about Immunotech S.A.S. itself.

On that basis, no functional description, core technology, or revenue mechanics can be reliably asserted from the input material. Any product offering, scientific platform, customer segment, or revenue model would constitute fabrication and is therefore omitted. The single defensible characterization is the company's legal form and the immunology-oriented naming convention, which is consistent with a small French biotech, life-sciences tools, or diagnostics research entity, but this remains an inference from the name alone and is not corroborated by the source data.

This is best understood as a data-gap case: the aggregated sources do not provide enough evidence to characterize Immunotech S.A.S.'s operations, commercial stage, or strategic position. Any downstream investment use of this output should treat it as a low-confidence entity pending primary-source confirmation of the company's products, customers, and financial profile.

Name

Immunotech S.A.S.

Website

https://beckmancoulter-amh.com

Company type

Private

Headcount range

11–50 employees

Short description

Immunotech S.A.S. is a French private company (S.A.S. legal form) whose name suggests an immunology-focused technology or research entity, though no products, customers, or operational details are disclosed in available source data.

Ownership category

akta.pro rank

Product category

Immunology Technology

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

SIC

In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Immunoassay Diagnostics (ELISA, chemiluminescence, serology) (HLAAALAB)

GTM type

B2B

Offering type

Services

Core offering

No substantive information about Immunotech S.A.S.'s offerings is present in the source data; the only artifact is a tracking pixel from beckmancoulter-amh.com.

Differentiator

Problem solved

Functional benefit

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Broad incumbents

• Beckman Coulter: Beckman Coulter is a broad incumbent in clinical diagnostics, including immunoassay systems and reagents. The company name Immunotech S.A.S. is associated with Beckman Coulter's domain (beckmancoulter-amh.com), suggesting a direct relationship.

Direct peers

• DiaSorin: DiaSorin specializes in in-vitro diagnostic reagents, particularly in immunodiagnostics and molecular diagnostics, making it a directly comparable peer to a company with 'Immuno' in its name.
• Bio-Rad Laboratories: Bio-Rad Laboratories is a major manufacturer of immunoassay reagents and clinical diagnostics products, directly comparable to a company named Immunotech focused on immunological diagnostics.

Market position

Competitive moat1 record

Key highlights1 record

Customer concentration

• LinkedInlinkedin.com/company/immunotech-s.a.s.

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Immunotech S.A.S.